New Insights into the PPAR□ Agonists for the Treatment of Diabetic Nephropathy
New Insights into the PPAR□ Agonists for the Treatment of Diabetic Nephropathy
About this item
Full title
Author / Creator
Publisher
New York: Hindawi Limiteds
Journal title
Language
English
Formats
Publication information
Publisher
New York: Hindawi Limiteds
Subjects
More information
Scope and Contents
Contents
Diabetic nephropathy (DN) is a severe complication of diabetes and serves as the leading cause of chronic renal failure. In the past decades, angiotensin-converting enzyme inhibitors (ACEIs)/angiotensin II receptor blockers (ARBs) based first-line therapy can slow but cannot stop the progression of DN, which urgently requests the innovation of ther...
Alternative Titles
Full title
New Insights into the PPAR□ Agonists for the Treatment of Diabetic Nephropathy
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_1503653169
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1503653169
Other Identifiers
ISSN
1687-4757
E-ISSN
1687-4765
DOI
10.1155/2014/818530
